TipRanks
Advertisement
Advertisement

DE:3G0 Stock Latest News

Altimmune management to meet with Truist
The FlyAltimmune management to meet with Truist
5d ago
ALT
Altimmune Appoints Richard Menziuso as Principal Accounting Officer
PremiumCompany Announcements
Altimmune Appoints Richard Menziuso as Principal Accounting Officer
14d ago
8K
ALT
Altimmune price target lowered to $17 from $18 at Evercore ISI
PremiumThe Fly
Altimmune price target lowered to $17 from $18 at Evercore ISI
20d ago
ALT
Altimmune Charts Long Runway with Bold Trial Push
PremiumCompany Announcements
Altimmune Charts Long Runway with Bold Trial Push
2M ago
ALT
Altimmune Maintained at Buy as Late-Stage Liver Programs Advance and $20 Price Target Remains Unchanged
PremiumRatings
Altimmune Maintained at Buy as Late-Stage Liver Programs Advance and $20 Price Target Remains Unchanged
2M ago
ALT
Altimmune reports Q2 EPS (12c), consensus (12c)
PremiumThe FlyAltimmune reports Q2 EPS (12c), consensus (12c)
2M ago
ALT
Is ALT a Buy, Before Earnings?
Premium
Pre-Earnings
Is ALT a Buy, Before Earnings?
2M ago
ALT
ALT Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
ALT Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
ALT
Altimmune initiates PERFORMA trial
PremiumThe Fly
Altimmune initiates PERFORMA trial
2M ago
ALT
Barclays says trial data highlights meaningful opportunity for Altimmune in AUD
PremiumThe Fly
Barclays says trial data highlights meaningful opportunity for Altimmune in AUD
3M ago
ALT
H.C. Wainwright sees ‘clear Phase 2 win’ for Altimmune
PremiumThe Fly
H.C. Wainwright sees ‘clear Phase 2 win’ for Altimmune
3M ago
ALT
Leerink remains bullish on Altimmune following ‘positive’ AUD trial results
PremiumThe Fly
Leerink remains bullish on Altimmune following ‘positive’ AUD trial results
3M ago
ALT
Unusually active option classes on open July 28th
PremiumThe FlyUnusually active option classes on open July 28th
3M ago
ALT
HTZ
Altimmune Reports Positive Phase 2 Data in AUD
Premium
Company Announcements
Altimmune Reports Positive Phase 2 Data in AUD
3M ago
8K
ALT
Altimmune announces RECLAIM trial met primary endpoint
Premium
The Fly
Altimmune announces RECLAIM trial met primary endpoint
3M ago
ALT
Unusually active option classes on open June 24th
PremiumThe Fly
Unusually active option classes on open June 24th
4M ago
BP
ALT
Altimmune initiated with an Outperform at Leerink
PremiumThe Fly
Altimmune initiated with an Outperform at Leerink
4M ago
ALT
Altimmune initiated with an Outperform at Leerink
PremiumThe Fly
Altimmune initiated with an Outperform at Leerink
4M ago
ALT
Altimmune Relocates Corporate Headquarters to Morristown, New Jersey
PremiumCompany Announcements
Altimmune Relocates Corporate Headquarters to Morristown, New Jersey
4M ago
8K
ALT
Altimmune reports 48-week data from IMPACT Phase 2b trial of pemvidutide
PremiumThe FlyAltimmune reports 48-week data from IMPACT Phase 2b trial of pemvidutide
5M ago
ALT
Altimmune price target lowered to $20 from $25 at H.C. Wainwright
Premium
The Fly
Altimmune price target lowered to $20 from $25 at H.C. Wainwright
5M ago
ALT
Altimmune price target lowered to $11 from $14 at Citizens
Premium
The Fly
Altimmune price target lowered to $11 from $14 at Citizens
5M ago
ALT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >